Grifols (GRFS) Return on Invested Capital (2011 - 2013)
Grifols (GRFS) posted Return on Invested Capital of 0.01% for Q1 2020, up 19.53% quarter-over-quarter from 0.01% in Q4 2019, and little changed year-on-year from 0.01% in Q2 2019.
Grifols (GRFS) Return on Invested Capital (2011 - 2013) Analysis & Trends
Grifols (GRFS) has reported Return on Invested Capital for 8 consecutive years, with 0.01% the latest figure, recorded in Q1 2020.
- Return on Invested Capital for Q1 2020 came in at 0.01%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2020 was 0.01% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
- Return on Invested Capital was 0.01% for Q1 2020 at Grifols, up from 0.01% in the prior quarter.
- Over five years, Return on Invested Capital peaked at 0.07% in Q2 2018 and troughed at 0.0% in Q1 2017.
- Average Return on Invested Capital over 5 years is 0.02%, with a median of 0.01% recorded in 2018.
- Year-over-year, Return on Invested Capital declined 1 bps in 2017 and advanced 6 bps in 2018.
- Over 5 years, Return on Invested Capital stood at 0.0% in 2016, then jumped by 306 bps to 0.01% in 2017, then soared by 81 bps to 0.01% in 2018, then fell by 13 bps to 0.01% in 2019, then grew by 20 bps to 0.01% in 2020.
- Per Business Quant data, the three most recent Return on Invested Capital figures were 0.01% in Q1 2020, 0.01% in Q4 2019, and 0.01% in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 0.00% |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 0.00% |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 0.00% |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 0.00% |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 0.00% |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 0.00% |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 0.00% |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Grifols | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 0.00% |
| Sep 30, 2013 | 0.00% |
| Jun 30, 2013 | 0.00% |
| Dec 31, 2012 | 0.00% |
| Sep 30, 2012 | 0.00% |
| Jun 30, 2012 | 0.00% |
| Mar 31, 2012 | 0.00% |
| Dec 31, 2011 | 0.00% |
| Sep 30, 2011 | 0.00% |